Pharma Marketing News Vol. 10, No. 10: 8 June 2011
Welcome to Volume 10, Issue #10 (8 JUNE 2011) of Pharma Marketing News.
Implications of Facebook’s Page Commenting Changes
A discussion with Jonathan Richman, Group Director, Insights and Planning at Possible Worldwide about Facebook's changes to its commenting policies and his recommendations for pharma marketers who wish to develop Facebook pages.
Pharma Marketing News Vol. 10, No. 9: 18 May 2011
Welcome to Volume 10, Issue #9 (18 MAY 2011) of Pharma Marketing News.
Consequences of eDetailing Technology
The Death of the Traditional Pharma Salesman and the Birth of the 'Sales Cyborg.' eDetailing in one form or another seems to be making a comeback since the recession hit the drug industry in 2007 and 2008. Which is the 'chicken' and which is the 'egg'? Did the uptick in adoption of eDetailing technology lead to the recent layoff of pharma reps or were reps laid off because of the economy and subsequently replaced by machines?
Real Patients Star in Pharma Youtube Videos
Pharma marketers save a bundle repurposing videos for Youtube. They save even more money by hiring real patients to play themselves in these videos! Patients are natural method actors, having actually experienced what they portray. But they are prone to over emote!
New Big Pharma Economies of Scale
How many patients are needed these days to make a drug a billion dollar blockbuster? Less than you think. What are the implications for pharmaceutical marketing?
Tracking Public Health Trends: Twitter vs Google vs Your Nose
Public health officials cannot depend upon their noses to make important decisions. They need actionable real time data. How do they get it?
Adobe Connect for eDetailing: Making Physician Communications More Effective
This article focuses on Adobe Connect for eDetailing, a specific collaboration between Adobe and ConnectSolutions, a leading provider of private cloud deployments of web conferencing and collaboration solutions.
A Pharma Social Media Conspiracy Theory: Were Guidelines Held Hostage as Part if FDA’s...
Were FDA's infamous 14 warning letters to pharma a ploy to force Google into a $500M DOJ settlement regarding illegal online pharmacy ads? In addition, could FDA have been holding back issuing pharma social media guidelines -- which would include guidelines for displayig compliant information in space-limited applications such as Twitter AND Google Adwords -- until Google settled its case with the DOJ?
Pharma Marketing News Vol. 10, No. 6: 29 MARCH 2011
Welcome to Volume 10, Issue #6 (30 MARCH 2011) of Pharma Marketing News.
